Table 1 Patient characteristics of the hemothorax (HTX) and non-hemothorax (No HTX) group with corresponding p values
Characteristics | HTX (N = 17) | No HTX (N = 115) | P |
|---|---|---|---|
Age (years) | 52 | 55 | 0.39 |
Gender (male) | 13/17 (76 %) | 55/114 (48 %) | 0.038 |
LAS | 57 | 51 | 0.27 |
Previous thoracotomy | 7/17 (41 %) | 33/115 (29 %) | 0.40 |
Bilateral Lung Transplant | 6/17 (35 %) | 33/115 (29 %) | 0.58 |
Pre-tx mPAP | 27 | 29 | 0.41 |
Pre-tx Hemoglobin | 12.7 | 12.3 | 0.51 |
Pre-tx Platelet | 242,000 | 259,000 | 0.52 |
Pre-tx Full Anticoagulation | 1/17 (6 %) | 9/115 (8 %) | 1.00 |
Pre-tx Aspirin | 4/17 (24 %) | 26/115 (23 %) | 1.00 |
Pre-tx Mechanical Ventilation | 1/17 (6 %) | 4/115 (3 %) | 0.50 |
Ischemic Time (minutes) | 221 | 186 | 0.15 |
Use of Cardiopulmonary Bypass | 11/17 (65 %) | 65/115 (57 %) | 0.61 |
Moderate-dense adhesions | 7/17 (41 %) | 33/115 (29 %) | 0.40 |
Intraoperative Transfusion: Units of PRBCs | 2.0 | 0.9 | 0.24 |
Post-tx Hemoglobin | 10.5 | 10.6 | 0.78 |
Post-tx Platelet | 157,000 | 168,000 | 0.49 |
Post-tx INR | 1.3 | 1.4 (N = 113) | 0.21 |
Post-tx PTT | 40 | 37 | 0.66 |
P/F Nadir by 72 hours | 224 | 256 | 0.19 |
Underlying Lung Disease: | |||
COPD | 1 | 19 | NS |
Bronchiectasis | 0 | 4 | |
IPF | 6 | 39 | |
ILD | 3 | 32 | |
Sarcoidosis | 4 | 12 | |
Re-transplantation | 2 | 4 | |
Other | 1 | 5 | |